aNeuSTART

Company Overview

Snapshot

Founded in March 2018 by Yael Kuperman and Maya Lebow, aNeuSTART operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its diagnostic kit.

Business overview

aNeuSTART is a Health Tech & Life Sciences company developing a non-invasive, at-home diagnostic kit for children with Autism Spectrum Disorder. The core technology involves detecting biological pathways impacting nutritional flow to the brain and using an algorithm to combine diagnostic results with health history, symptoms, and diet. The company provides personalized action plans, including recommendations for supplements and foods, tailored to each child's unique biochemistry to improve overall functioning. aNeuSTART operates in the Digital Healthcare sector, serving patients globally with a focus on nutrient-based interventions for children.

Company Intelligence Q&A

What is aNeuSTART's primary focus?

aNeuSTART is focused on developing an at-home diagnostic kit for children with Autism Spectrum Disorder to create personalized, nutrient-based action plans.

When was aNeuSTART founded?

aNeuSTART was founded in March 2018.

Who are the founders of aNeuSTART?

aNeuSTART was co-founded by Yael Kuperman and Maya Lebow.

What is the current employee size of aNeuSTART?

aNeuSTART currently has 1–10 employees.

What kind of product is aNeuSTART developing?

aNeuSTART is developing a noninvasive, at-home diagnostic kit that detects biological pathways impacting nutritional flow to the brain, combined with an algorithm for personalized recommendations.